10X Genomics Stock Hits Day Low of $15.90 Amid Price Pressure

10X Genomics, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 11.18%. The stock reached an intraday low of USD 15.90, reflecting a challenging trading session. Over the past week, 10X Genomics has seen a notable decrease of 20.18%, contrasting sharply with the S&P 500's slight decline of 1.42%. In the longer term, the stock's performance remains mixed; while it has gained 61.41% over the past year, it has faced substantial losses of 66.83% over the last three years and 90.11% over the past five years. Despite the recent downturn, the company has demonstrated strong institutional support, with holdings at 100%. This backing suggests a robust analytical capability among its investors. Financial metrics indicate that while the stock has generated a return of 90.18% in the last year, its profits have only increased by 25.6%, highlighting a disparity in growth versus stock performance. The company's market capitalization stands at USD 2,412 million, and it currently does not offer a dividend.